Lexicon Pharmaceuticals (LXRX) Capital Expenditures Growth (5y) (2015 - 2023)
Lexicon Pharmaceuticals (LXRX) Capital Expenditures Growth (5y) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Lexicon Pharmaceuticals | 888.49 Mn | 717.83 Mn | 20.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 94.26% |
| Jun 30, 2023 | 56.09% |
| Mar 31, 2023 | 44.04% |
| Dec 31, 2022 | 215.28% |
| Sep 30, 2022 | -42.01% |
| Mar 31, 2022 | -3.75% |
| Dec 31, 2021 | -31.09% |
| Sep 30, 2021 | 67.82% |
| Jun 30, 2021 | 135.77% |
| Mar 31, 2021 | -6.79% |
| Dec 31, 2020 | -26.16% |
| Sep 30, 2020 | -29.08% |
| Mar 31, 2019 | 20.11% |
| Dec 31, 2018 | -29.67% |
| Sep 30, 2018 | -59.28% |
| Jun 30, 2018 | -48.12% |
| Mar 31, 2018 | -45.59% |
| Dec 31, 2017 | -48.74% |
| Sep 30, 2017 | 4.06% |
| Jun 30, 2017 | -5.66% |